Bone Density in Patients With Berardinelli-Seip Congenital Lipodystrophy Is Higher in Trabecular Sites and in Type 2 Patients
Abstract Berardinelli-Seip congenital lipodystrophy (BSCL) is a rare autosomal recessive syndrome characterized by a difficulty storing lipid in adipocytes, low body fat, hypoleptinemia, and hyperinsulinemia. We report here laboratory, bone mineral density (BMD), and bone mineral content findings of...
Gespeichert in:
Veröffentlicht in: | Journal of clinical densitometry 2018-01, Vol.21 (1), p.61-67 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Abstract Berardinelli-Seip congenital lipodystrophy (BSCL) is a rare autosomal recessive syndrome characterized by a difficulty storing lipid in adipocytes, low body fat, hypoleptinemia, and hyperinsulinemia. We report here laboratory, bone mineral density (BMD), and bone mineral content findings of 21 patients (24.1 ± 8.4 yr old, 14 females, 18 diabetics, 5.3% total body fat) with BSCL. The mean leptin was very low (0.91 ± 0.42 ng/mL), and the mean values of the Z -scores for all studied sites were positive, except for the 33% radius ( Z -score −0.5 standard deviation [SD]). Twelve patients (57.1%) had a BMD Z -score higher than +2.5 SD in at least 1 site. There was no significant difference in the Z -scores between males and females. None of type 1 ( AGPAT2 ) patients had Z -scores higher than +2.5 SD, and these patients had a smaller Z -score of BMD total body (0.26 SD vs 1.90 SD, p = 0.022) and of bone mineral content (1.59 SD vs 3.3 SD, p = 0.032) than type 2 (seipin) patients. Insulin, as well as HOMAIR (homeostasis model assessment), correlated positively with the BMD of all sites, except for the 33% radius. Z -Scores on this site (33% radius) were the smallest of all. More than half of our patients with BSCL have BMD Z -scores higher than +2.5 SD on at least 1 site, and this increase is more pronounced in the trabecular sites and in type 2 patients. |
---|---|
ISSN: | 1094-6950 1559-0747 |
DOI: | 10.1016/j.jocd.2016.10.002 |